Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Penumbra Sweden AB
AB
Active
Org 5593758310
Växjö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2022
5 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Penumbra Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
5M
10M
16M
21M
3M
2022
18M
2023
15M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
2 950
17 920
14 792
Staff expenses
—
—
—
EBITDA
218
1 299
1 194
Depreciation & amort.
−0
−0
−0
EBIT
218
1 299
1 194
Net financials
—
11
1
Profit before tax
219
1 311
1 196
Tax
−45
−473
−259
Net profit
174
838
937
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
3 342
4 274
23 126
Equity
199
1 036
1 973
Long-term debt
0
0
17 729
Short-term debt
3 144
3 238
3 424
Total debt
3 144
3 238
21 153
Financial ratios
5-year trend
EBITDA margin
8.1%
This company
15.8%
Market median
-49% vs market
2022
2024
Equity ratio
8.5%
This company
38.2%
Market median
-78% vs market
2022
2024
Return on equity
47.5%
This company
18.4%
Market median
+158% vs market
2022
2024
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
2022
2024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
2022
2024
Debt / equity
10.72×
This company
0.62×
Market median
-1629% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2022-12-31
View
PDF
More on Penumbra Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot